Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yan Ting Hee"'
Publikováno v:
npj Systems Biology and Applications, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Engineered microorganisms have emerged as viable alternatives for limonene production. However, issues such as low enzyme abundance or activities, and regulatory feedback/forward inhibition may reduce yields. To understand the underlying met
Externí odkaz:
https://doaj.org/article/42937daf53594e4886801272335a0d11
Autor:
Wee-Joo Chng, Michael Sebag, Daniel D. Waller, Qi Zeng, Zea Tuan Tan, Tae-Hoon Chung, Jing-Yuan Chooi, Yan Ting Hee, Julia S.L. Lim, Jianbiao Zhou, Phyllis S.Y. Chong
Table S1: RT-PCR primers Figure S1: mRNA and protein expression of PRL-3 in HMCLs. Figure S2. IL-6 treatment of MM cell lines. Figure S3. Cellular effects of PRL-3 knockdown in HMCLs. Figure S4. Treatment of BTZ-resistant cells with PRL-3 inhibitor I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3e934dc13d07109ecfabbd698dd1cd4
https://doi.org/10.1158/0008-5472.22421531
https://doi.org/10.1158/0008-5472.22421531
Autor:
Wee-Joo Chng, Michael Sebag, Daniel D. Waller, Qi Zeng, Zea Tuan Tan, Tae-Hoon Chung, Jing-Yuan Chooi, Yan Ting Hee, Julia S.L. Lim, Jianbiao Zhou, Phyllis S.Y. Chong
Overexpression of PRL-3, an oncogenic phosphatase, was identified as a novel cluster in patients with newly diagnosed multiple myeloma. However, the regulation and oncogenic activities of PRL-3 in multiple myeloma warrant further investigation. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31066edb2b06953929b10ec839abaea9
https://doi.org/10.1158/0008-5472.c.6510956
https://doi.org/10.1158/0008-5472.c.6510956
Publikováno v:
Oncotarget
Natural killer/T-cell lymphoma (NKTCL) is an aggressive non-Hodgkin lymphoma that has been facing limited success with conventional treatments, urging for the discovery of alternative strategies. Recent studies including ours have revealed that EZH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e1d70c0649efd1b2ba6b5e27445e3f
https://doi.org/10.18632/oncotarget.25835
https://doi.org/10.18632/oncotarget.25835
Autor:
Jing Yuan Chooi, Wee Joo Chng, Qi Zeng, Julia S.L. Lim, Daniel D Waller, Michael Sebag, Jianbiao Zhou, Tae-Hoon Chung, Yan Ting Hee, Phyllis S.Y. Chong, Zea Tuan Tan
Publikováno v:
Cancer research. 79(18)
Overexpression of PRL-3, an oncogenic phosphatase, was identified as a novel cluster in patients with newly diagnosed multiple myeloma. However, the regulation and oncogenic activities of PRL-3 in multiple myeloma warrant further investigation. Here,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5010d6dede174f4938beceb2a9130849
https://pubmed.ncbi.nlm.nih.gov/31337650
https://pubmed.ncbi.nlm.nih.gov/31337650
Autor:
Nurulhuda Mustafa, Adina Huey Fang Nee, Jennifer Yang, Viknesvaran Selvarajan, Sabrina Hui Min Toh, Longen Zhou, Jing Yuan Chooi, Wee Joo Chng, Yan Ting Hee
Publikováno v:
Blood. 132:1663-1663
Complement-dependent cytotoxicity (CDC) is one of the major mechanisms mediating the anti-tumor efficacy of Daratumumab. We have previously demonstrated that a majority of Natural Killer/T- Cell Lymphoma (NKTL) patient samples express CD38 and Daratu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ecdea5d33e0dedf46cf7485b8218cb
https://doi.org/10.1182/blood-2018-99-115566
https://doi.org/10.1182/blood-2018-99-115566